SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
# FDA Approves Hikma Pharmaceuticals' Intravenous Allopurinol Sodium Formulation Hikma Pharmaceuticals USA Inc. received FDA approval for allopurinol...
Impax Labs announced the July 30, 2004 approval of an Abbreviated New Drug Application (ANDA 076249) from the FDA, marking a significant milestone for...
SpecGx LLC announced FDA approval of the 40 mg and 80 mg strengths of the generic version of Oxycontin (oxycodone hydrochloride) on Tuesday. The avail...
On June 16, 2004, ACTAVIS LABS FL INC received FDA approval for ANDA076172, allowing the company to launch a generic drug without a specific brand or ...
The FDA approved Actavis Pharma, Inc.'s application for the generic oral version of Fioricet With Codeine (butalbital, acetaminophen, caffeine, and co...
IVAX SUB TEVA PHARMS received FDA approval for ANDA076089 on June 9, 2004, paving the way for the launch of a new generic drug that barring patent cha...
Amneal Pharmaceuticals received FDA approval to manufacture the generic version of brand-name CARBIDOPA AND LEVODOPA formulations, providing additiona...
# FDA Approves Eli Lilly's ZYPREXA Intramuscular Formulation Eli Lilly and Company received FDA approval for ZYPREXA (olanzapine) intramuscular injec...
On February 27, 2004, the FDA approved the oral version of Novartis Pharmaceuticals Corporation's immunosuppressant Myfortic (mycophenolic acid), allo...
Actavis Labs FL Inc. secured FDA approval for its generic product, bolstering its financial outlook by expanding its portfolio in a highly competitive...
Watson Labs received an FDA approval that is expected to enhance revenue growth as the company prepares to launch a new generic product. This approval...
# FDA Approves AstraZeneca's CRESTOR (rosuvastatin calcium) for Cholesterol Management AstraZeneca Pharmaceuticals LP has received FDA approval for C...
# FDA Approves Fresenius Kabi's Intravenous Valproate Sodium Formulation Fresenius Kabi USA, LLC received FDA approval for its intravenous valproate ...
Genentech’s (CHI.HS) FDA approval of its subcutaneous administration of OMALIZUMAB for XOLAIR in June 2003 launched a blockbuster franchise that revol...
# FDA Approves Amneal Pharmaceuticals' Epinephrine Injection Amneal Pharmaceuticals of New York LLC has received FDA approval for its subcutaneous ep...
Novartis Pharmaceuticals marked a decisive revenue milestone with the FDA approval of the blockbuster oncology agent Gleevec in 2003, a pivotal advanc...
Uronova Pharmaceuticals announced the FDA approval of Vabrimty, a generic Leuprolide Acetate injection, which positions the company to compete directl...
Prasco Laboratories' earlier approval of the synthetic peptide teriparatide establishes a foundational market presence for the osteoporosis treatment,...
Eli Lilly and Company has announced that the capsule form of its branded attention deficit hyperactivity disorder (ADHD) medication STRATTERA (atomoxe...
# FDA Approves Sagent Pharmaceuticals' Intravenous Valproate Sodium Formulation Sagent Pharmaceuticals has received FDA approval for its intravenous ...